Aránzazu Manzano

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 931 citations · Full text

Medicine, Oncology, Pharmacology +17

Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Juan Virizuela Echaburu et al. · Journal of Clinical Oncology · 2015 · 161 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

Integrated mutational landscape analysis of uterine leiomyosarcomas

Jungmin Choi, Aránzazu Manzano, Weilai Dong et al. · Proceedings of the National Academy of Sciences · 2021 · 118 citations · Full text

Medicine, Genetics, Oncology +17

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Charles H. Li, Elena Bonazzoli, Stefania Bellone et al. · Proceedings of the National Academy of Sciences · 2018 · 99 citations · Full text

Medicine, Cancer Biology, Oncology +17

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Luca Zammataro, Salvatore Lopez, Stefania Bellone et al. · Proceedings of the National Academy of Sciences · 2019 · 94 citations · Full text

Medicine, Genetics, Oncology +17